Tirzepatide cost with insurance
How insurance changes what you pay for tirzepatide — covered copays, savings cards, Medicare limits, and where cash-pay compounded can still win.
Tirzepatide cost with insurance
Coverage hinges on the diagnosis and your specific plan. Brand-name products can be covered; compounded tirzepatide generally is not.
| Scenario | Type | Typical cost | FDA status |
|---|---|---|---|
| Commercial plan covers Zepbound + savings card | Brand | as low as $25/mo | FDA-approved |
| Commercial plan, no weight coverage + savings card | Brand | up to ~$499 off/fill | FDA-approved |
| Mounjaro covered for type 2 diabetes | Brand | plan copay | FDA-approved |
| Medicare/Medicaid (weight loss) | Brand | generally excluded* | FDA-approved |
| Compounded tirzepatide | Compounded | not covered (cash-pay $186+) | Not FDA-approved |
*Medicare Part D has generally excluded weight-loss drugs; a 2026 Medicare GLP-1 pathway is rolling out for some beneficiaries — verify your current eligibility. Manufacturer savings cards require commercial insurance and exclude government plans.
Reading your coverage
If your commercial plan covers Zepbound for weight management, the Lilly savings card can bring copays as low as $25. If it doesn't, you may still get a per-fill discount, but many patients find cash-pay compounded pricing (from $186/month) lower than an uncovered brand copay. Mounjaro is typically covered only for type 2 diabetes. Compounded tirzepatide is cash-pay and not FDA-approved. Compare routes on the full price guide.
Questions
Does insurance cover tirzepatide for weight loss?
Some commercial plans cover brand-name Zepbound for weight management; with the Lilly savings card copays can be as low as $25. Coverage depends on your plan and diagnosis. Compounded tirzepatide is generally not covered. See NexLife pricing
Why isn't compounded tirzepatide covered by insurance?
Compounded medications are not FDA-approved and are typically dispensed cash-pay, so insurers generally don't cover them. Many programs accept HSA/FSA.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.